IP Library Granted Patent US 8,747,922
Granted Patent B2
US 8,747,922 · App. 13/623,105 · Granted Jun 10, 2014

Methods and compositions for increasing sex steroids and growth hormones

Inventors: Amy L. Heaton (Salt Lake City, UT); Mitchell K. Friedlander (Salt Lake City, UT); Dennis Gay (Salt Lake City, UT)
Assignee: Quality IP Holdings, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,747,922
App. No.
13/623,105
Granted
Jun 10, 2014
Kind
B2
Abstract

Embodiments of the invention generally relate to methods and supplements for increasing sex steroids and human growth hormone in a human being.

Claims (29)

1. A method for increasing sex steroids and human growth hormone in a human being in need thereof, the method comprising:

providing an oral nutritional supplement unit dosage form, wherein the oral nutritional supplement unit dosage form consists essentially of about 1 mmol L-arginine, about 1 mmol Oxo-proline, about 2 mmol L-lysine, about 1.5 μmol N-acetyl L-cysteine, about 2 μmol L-glutamine, and about 125 μg Schizonepta (aerial parts) powder; and

orally administering an effective amount of the nutritional supplement to the human being.

2. The method according to claim 1 , wherein the oral nutritional supplement unit dosage form consists of:

0.86 mmol L-arginine;

1.32 mmol Oxo-proline;

2.05 mmol L-lysine;

1.53 μmol N-acetyl L-cysteine;

1.71 μmol L-glutamine; and

1.25 μg Schizonepta (aerial parts) powder.

3. The method according to claim 2 , wherein the oral nutritional supplement unit dosage form consists of 181.38 mg L-arginine HCl; 170.93 mg L-pyroglutamic acid; 374.83 mg L-lysine HCl; 0.25 mg N-acetyl L-cysteine USP; 0.25 mg L-glutamine; and 0.125 mg Schizonepta (aerial parts) powder.

4. The method according to claim 1 , wherein the oral nutritional supplement unit dosage form is administered to the human being, so as to increase lean body mass or libido; reduce obesity, adipose tissue mass, or anxiety; support weight loss; decrease appetite and atrophic processes in skeletal muscle, liver, kidney, spleen, skin, or bone; improve energy, endurance, sleep, metabolism, heart rate, blood pressure, cardiovascular health, sympathetic nervous activity, thyroid response, fat metabolism, glucose utilization, mental/cognitive function, reaction time, bone density, hair health and appearance, nail health and appearance, skin health and appearance, or libido; and/or affect one or more condition(s) and/or disease(s) that depend upon androgen activity.

5. The method according to claim 1 , wherein the oral nutritional supplement unit dosage form is in capsule form.

6. The method according to claim 1 , wherein the oral nutritional supplement unit dosage form is orally administered in a total amount of 2.9 grams.

7. The method according to claim 6 , wherein the oral nutritional supplement is administered from one to three times daily.

8. The method according to claim 6 , wherein the oral nutritional supplement is administered once a week.

9. The method according to claim 6 , wherein the oral nutritional supplement is administered on an empty stomach.

10. The method according to claim 6 , wherein the human being is at least 30 years old.

11. The method according to claim 6 , wherein the human being exhibits one or more symptoms of post-traumatic stress disorder selected from the group consisting of re-experiencing the original trauma(s) through flashbacks or nightmares, avoidance of stimuli associated with the trauma, increased arousal, difficulty falling or staying asleep, anger, and hypervigilance.

12. A method for improving health in a human being by increasing levels of testosterone in a human being in need thereof, the method comprising:

orally administering an oral nutritional supplement unit dosage form to the human being, wherein the oral nutritional supplement unit dosage form consists of 3.44 mmol L-arginine; 5.30 mmol Oxo-proline; 8.21 mmol L-lysine; 6.13 μmol N-acetyl L-cysteine; 6.84 μmol L-glutamine; and 0.50 mg Schizonepta (aerial parts) powder.

13. The method according to claim 12 , wherein the oral nutritional supplement unit dosage form consists of 725.50 mg L-arginine HCl; 683.70 mg L-pyroglutamic acid; 1499.30 mg L-lysine HCl; 1.00 mg N-acetyl L-cysteine USP; 1.00 mg L-glutamine; and 0.50 mg Schizonepta (aerial parts) powder.

14. The method according to claim 12 , wherein the oral nutritional supplement unit dosage form is in capsule form.

15. The method according to claim 12 , wherein the oral nutritional supplement unit dosage form is orally administered in a total amount of 2.9 grams.

16. The method according to claim 15 , wherein the oral nutritional supplement is administered from one to three times daily.

17. The method according to claim 15 , wherein the oral nutritional supplement is administered once a week.

18. The method according to claim 15 , wherein the oral nutritional supplement is administered on an empty stomach.

19. The method according to claim 15 , wherein the human being is at least 30 years old.

20. The method according to claim 15 , wherein the human being exhibits one or more symptoms of post-traumatic stress disorder selected from the group consisting of re-experiencing the original trauma(s) through flashbacks or nightmares, avoidance of stimuli associated with the trauma, increased arousal, difficulty falling or staying asleep, anger, and hypervigilance.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Jan 5, 2023
From: CASPAR CAPITAL LP
To: QUALITY IP HOLDINGS LLC
Reel/Frame 062283/0073 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2022
From: CERBERUS BUSINESS FINANCE, LLC
To: CASPAR CAPITAL LP
Reel/Frame 061636/0625 →
ASSIGNMENT OF SECURITY INTEREST Recorded Dec 30, 2019
From: LS2, LLC
To: CERBERUS BUSINESS FINANCE, LLC
Reel/Frame 051447/0114 →
SECURITY INTEREST Recorded Aug 21, 2015
From: QUALITY IP HOLDINGS, LLC
To: LS2, LLC
Reel/Frame 036392/0053 →
ASSIGNMENT FOR SECURITY - PATENTS Recorded Dec 4, 2014
From: QUALITY IP HOLDINGS, LLC
To: CERBERUS BUSINESS FINANCE, LLC, AS COLLATERAL AGENT
Reel/Frame 034535/0294 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE'S NAME PREVIOUSLY RECORDED AT REEL: 032089 FRAME: 0938. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 12, 2014
From: HEATON, AMY L.; FRIEDLANDER, MITCHELL K.; GAY, DENNIS
To: QUALITY IP HOLDINGS, LLC
Reel/Frame 033522/0072 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 30, 2014
From: HEATON, AMY L.; FRIEDLANDER, MITCHELL K.; GAY, DENNIS
To: QUALITY IP HOLDINGS, INC.
Reel/Frame 032089/0938 →
Continuity (1)
Related Publication 20140079824A1 · Mar 20, 2014